Walleye Capital LLC Ab Cellera Biologics Inc. Call Options Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$3.91 - $5.93 $118,082 - $179,086
30,200 Added 3355.56%
31,100 $177,000
Q3 2023

Nov 14, 2023
SELL
$4.6 - $7.95 $2,760 - $4,770
-600 Reduced 40.0%
900 $4,000
Q2 2023

Aug 14, 2023
BUY
$5.66 - $7.59 $8,490 - $11,385
1,500 New
1,500 $9,000
Q3 2022

Nov 14, 2022
BUY
$9.2 - $13.68 $15,639 - $23,256
1,700 New
1,700 $17,000

Others Institutions Holding ABCL

# of Institutions
154
Shares Held
109M
Call Options Held
153K
Put Options Held
194K
View Full List

About AbCellera Biologics Inc.

ABCL Quotes by TradingView
  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $841M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email